If Amazon.com Inc. hopes to become a big player in the multitrillion-dollar healthcare industry, the e-commerce company will have to buy its way in, one midsize deal at a time, S&P Global reports. The Federal Trade Commission is reviewing Amazon’s plans to purchase 1Life Healthcare Inc., the parent company of One Medical. Analysts are optimistic that regulators will allow the deal because of its relatively modest value, at $4.30 billion, and the competitive nature of the healthcare market. Tuck-in deals valued below $10 billion are Amazon’s “sweet spot” in that they are more likely to bypass intense government scrutiny, said Tom Forte, managing director with D.A. Davidson. Read more.
Amazon’s Healthcare Ambitions Hinge on Smaller Deals That Survive FTC Scrutiny
